Lowenstein Represents Long Time Client Crown Laboratories, Portfolio Company of Hildred Capital, in Acquisition of Eclipse MedCorp’s Assets

Lowenstein Sandler represented Crown Laboratories, Inc. ("Crown"), a leading, fully integrated global skincare company, in its agreement with Eclipse MedCorp LLC, a medical technology company, to acquire its global, aesthetics-focused assets. The acquisition expands Crown's aesthetics' product portfolio and enhances its overall value proposition as a global leader in science-based aesthetic skincare solutions. Crown is a portfolio company of Hildred Capital Management, LLC.

Crown will integrate the Eclipse products into the aesthetics business unit of Crown to complement its award-winning SkinPen® Precision and other brands. Eclipse customers can expect to continue receiving superior customer service, medical education, and access to Crown's expanded range of highly effective aesthetic products.

Lowenstein has also represented Crown and Hildred in the acquisition of global skincare company StriVectin®; the acquisition of North American rights to Keri® from GlaxoSmithKline(GSK); and the acquisition of a portfolio of top-rated GSK products, including: PanOxyl®, a leading acne wash; Sarna, an anti-itch lotion; Zeasorb, an anti-fungal prevention product; Desenex®, an anti-fungal powder; and Mineral Ice®, a leading pain-relieving gel.

The Lowenstein deal team included: Sam E. Khan, Mitchell McDonald, Danielle M. Falzone, Kaitlyn M. Baietto,Maxwell Berteletti, Nicholas G. Mehler, Robert J. Paradiso, Jenna-Marie Tracy, Eric Jesse, Michael J. Scales, Kristin V. Taylor, Amy Komoroski Wiwi, Darren Goodman, Taryn E. Cannataro, James C. Shehan, Matthew M. Oliver, Craig Dashiell, Theodore C. Sica, Fran Skoller, Geena M. Caporale, and Julie Levinson Werner.

About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.

Contact(s):
Penny Paul
Sr. Manager, Marketing Communications
Lowenstein Sandler LLP
(973) 597-2592
[email protected]